FeNO Test and Asthma Medication

Introducing our state-of-the-art device, designed to effectively manage asthma symptoms. The Exhaled Nitric Oxide (FeNO) measurement it provides is a diagnostic element for airway inflammation, particularly eosinophilic inflammation, often linked with asthma. An elevated FeNO level hints at inflammation in the airways, requiring swift action to control asthma symptoms. Our device assists in choosing the suitable medication - usually inhaled corticosteroids (ICS) – which serves as a powerful anti-inflammatory treatment for asthma by suppressing airway inflammation.

Key ICS medications for asthma patients with high FeNO levels:

•           Fluticasone (Flovent): Available in assorted formulations, such as Flovent HFA and Flovent Diskus.

•           Budesonide (Pulmicort): Available as a nebulizer solution, inhalation suspension, and as a dry powder inhaler.

•           Beclomethasone (Qvar): Qvar is an inhaled corticosteroid available in an aerosol inhaler.

•           Mometasone (Asmanex): Available as an inhalation powder.

By reducing inflammation in the airways, these medications control asthma symptoms and prevent exacerbations. The specific medication and dosage hinge on the severity of asthma, the patient's treatment response, and individual factors. Regular assessment and adjustment of the treatment plan by healthcare providers are crucial.

Deciphering the Asthma Treatment Medication Dosage

While FeNO measurements offer key details about airway inflammation, they do not solely dictate the medication dosage for asthma. Asthma management entails a comprehensive approach, considering various factors:

•           Clinical Symptoms: Patient-reported symptoms like coughing, wheezing, shortness of breath, and nighttime awakenings are influential in determining medication adjustments.

•           Lung Function Tests: Tests like Spirometry help assess the severity of airflow obstruction and offer objective lung function measures.

•           Frequency and Severity of Exacerbations: The number and intensity of asthma attacks should be pondered while adjusting medication dosage.

•           Individual Response to Treatment: Monitoring how the patient responds to ongoing medication, including any side effects or inadequate symptom control, is vital.

•           Overall Asthma Control: Evaluating the overall asthma control, which includes symptom control and medication side effects, is crucial for informed decisions about medication dosage.

FeNO measurements are a useful tool in asthma management, especially in identifying eosinophilic inflammation. However, the decision to adjust medication dosage should be made by healthcare professionals after a thorough evaluation of the patient's clinical condition, symptoms, and other relevant factors. Regular follow-ups with healthcare providers are crucial for effective asthma management.